| 1 |
Ian Osterloh |
Amarin Pharmaceuticals Ireland Limited |
7 |
| 2 |
Khan Baykaner |
Nokia Technologies Oy |
4 |
| 2 |
Allan Warrington |
Intersil Americas |
4 |
| #4 |
Mark Andrews |
Pfizer |
3 |
| #4 |
Paul Snaith |
Arq Ip Limited |
3 |
| #4 |
Martin Scaife |
The Procter & Gamble |
3 |
| #7 |
Jonathan James Knight |
— |
2 |
| #7 |
Hamish C. Hunt |
IBM |
2 |
| #7 |
Michael David Simmonds |
Bae Systems Plc |
2 |
| #7 |
Tanya Jeane Knight |
Lonza |
2 |
| #11 |
Richard Angus Fownes Buchanan |
An Udder Ip Company |
1 |
| #11 |
Dennis Douroumis |
Delta Pharmaceuticals |
1 |
| #11 |
Peter Edward Vinson |
Edward Vinson |
1 |
| #11 |
Joseph Hashim |
Palantir Technologies |
1 |
| #11 |
Anwar Ali |
Delta Pharmaceuticals |
1 |
| #11 |
Graham Alexander Young |
— |
1 |
| #11 |
Thomas Jenkinson |
Darktrace Holdings Limited |
1 |
| #11 |
Richard Lumb |
— |
1 |
| #11 |
J. W. Barry Bruckmann |
— |
1 |
| #11 |
Jonathan Packham |
Cubic |
1 |
| #11 |
Saumil Kiritkumar Bhatt |
Delta Pharmaceuticals |
1 |
| #11 |
Francis Raphael Gressani |
Perkins Engines Company Limited |
1 |
| #11 |
Duncan McHale |
Evelo Biosciences |
1 |
| #11 |
Peter Pryce |
Abgene Limited |
1 |
| #11 |
Mohammed Maniruzzaman |
Delta Pharmaceuticals |
1 |
| #11 |
Michael Douglas BURTON |
— |
1 |
| #11 |
Arun Jangra |
Delta Pharmaceuticals |
1 |